Charlotte, North Carolina 28203

  • Patients Undergoing Contrast Enhanced Multidetector Computed Tomography of the Chest, Abdomen, Liver or Aorta for Any Diagnostic Cause

Purpose:

Collection of data from different sites regardless of whether they use standard or tailored protocols for the application of high concentration iodinated contrast agents to assess if the individually patient-adapted protocols result in a similar diagnostic image quality.


Study summary:

To record technical information and compare image quality regarding routine MDCT procedures with contrast administration using a tailored contrast injection and radiation dose protocol. The hypotheses are that the tailored protocols lead to a lower applied mean radiation dose compared to the use of standard protocols and will provide a more standardized contrast dose per patient size without impairing diagnostic quality.


Criteria:

Inclusion Criteria: - At least 18 years of age - Scheduled to undergo contrast enhanced MDCT of the abdomen, liver, aorta, or chest - Provides written informed consent Exclusion Criteria: - Previously enrolled and completed the study - Known allergy to iodinated contrast media - Pregnancy or lactation - Clinically unsuitable for the study


NCT ID:

NCT01737333


Primary Contact:

Study Director
Martin Krix, M.D.
Bracco Diagnostics, Inc


Backup Contact:

N/A


Location Contact:

Charlotte, North Carolina 28203
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: June 24, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.